Tay Therapeutics
PrivateLast Round
Grant
Oct 1, 2023
Total Funding Raised
$430,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Tay Therapeutics operates in Healthcare & Life Sciences and is based in Dundee. Its latest recorded funding round was a Grant round in October 2023.
Tay Therapeutics is a biotechnology company that develops targeted small molecule therapies for inflammatory conditions and rare genetic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tay Therapeutics Comparables
Compare Tay Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nonsense Therapeutics | 92% | |
| Eloxx Pharmaceuticals, Inc. | 77% | |
| Anima Biotech | 73% |
For institutional investors. Book with your work email.
Tay Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 1, 2023 | ||||
| VC Round | Nov 2, 2021 | ||||
| Seed | Nov 27, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Tay Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| o2h ventures | Seed, VC Round |
| Meltwind Advisory | Seed, VC Round |
| Innovate UK | Grant |
| Wren Capital | Seed, VC Round |
| Scottish Investment Bank (Scottish Enterprise) | Seed, VC Round |
| University of Dundee | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 51% MoM, reaching 1.1K.
- Oct 1, 2023
$430K grant received from Innovate UK.
For institutional investors. Book with your work email.
Tay Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Tay Therapeutics's valuation, stock price, and market status.
Is Tay Therapeutics a public or private company?
Tay Therapeutics is a private company.
What is the current stock price of Tay Therapeutics?
Tay Therapeutics is a private company, so its shares have no public market price. Caplight tracks Tay Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Tay Therapeutics worth (valuation)?
Valuation information for Tay Therapeutics is not publicly available.
Can I buy Tay Therapeutics stock?
Tay Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Tay Therapeutics's last funding round?
Tay Therapeutics's most recent funding round was Grant on October 1, 2023.
Who are the main investors in Tay Therapeutics?
Key investors in Tay Therapeutics include o2h ventures.
Will Tay Therapeutics IPO soon?
No public IPO plans have been announced for Tay Therapeutics.
How can I track Tay Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Tay Therapeutics's shares on secondary markets.